ERcast: Clinical Perspectives Podcast Preview
The summary below is from an episode of ERcast: Clinical Perspectives
Anaphylaxis is a rapid systemic hypersensitivity reaction that can be fatal even without hives or obvious airway findings. Severe disease, biphasic recurrence, and refractory anaphylaxis all change ED diagnosis, observation, and follow-up, with epinephrine remaining the treatment that matters most.
Anaphylaxis Diagnosis and Risk
- Skin findings not required: Severe anaphylaxis can present with life-threatening respiratory or circulatory compromise without rash, wheeze, or shock, a pattern that drives under-recognition in the ED.
- Infant diagnostic criteria: Infants and toddlers lack dedicated anaphylaxis criteria, so NIAD/FAAN or WAO definitions are the practical framework when symptoms look nonspecific. We walk through the gray-zone presentations in the episode.
- Biphasic reaction framing: Biphasic anaphylaxis is recurrence after symptoms have fully resolved for at least 1 hour, without re-exposure, and higher initial severity makes that rebound more likely.
- Refractory disease signal: Refractory anaphylaxis persists despite appropriate epinephrine and symptom-directed care, a high-risk phenotype linked to increased fatality and the need for aggressive escalation.
- Unexpected trigger caution: A first-ever exposure to a new food or medication is an unlikely cause of anaphylaxis, a useful clue when the presumed trigger does not fit the story.
Management, Observation, and Follow-up
- Epinephrine auto-injector dosing: For children under 15 kg, either the 0.1 mg or 0.15 mg IM epinephrine auto-injector is acceptable, reflecting the limited but practical pediatric guidance.
- Observation time principle: The more interventions required to stabilize an anaphylactic patient, the longer ED observation should be, especially when repeat epinephrine is needed. We get into the disposition nuance in the chapter.
- Acute tryptase timing: A tryptase level drawn as early as possible, ideally within 2 hours of symptom onset, can later help an allergist confirm that a true mast-cell event occurred.
- Baseline tryptase comparison: A second tryptase measured months later provides a baseline comparator, letting immunology interpret whether the acute value represented a significant rise.
- Discharge education essentials: High-risk patients should routinely leave with self-injectable epinephrine, technique teaching, and avoidance counseling, including that food anaphylaxis is usually triggered by ingestion rather than contact or inhalation.
Subscribe to ERcast: Clinical Perspectives to listen to the episode.
References:
- Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: A 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132(2):124-176. PMID: 38108678
Faculty
- Drew Kalnow, DO
Dr. Drew Kalnow is an emergency medicine physician and educator based in Columbus, Ohio. He completed his emergency medicine training at OhioHealth Doctors Hospital Emergency Medicine Residency. Dr. Kalnow is passionate about advancing emergency medicine through high-quality education, with a particular focus on simulation, learning theory, and innovative teaching.
- Andy Little, DO
Dr. Andy Little is an emergency medicine physician and educator. He earned his medical degree from the Ohio University Heritage College of Osteopathic Medicine and completed his emergency medicine residency at OhioHealth Doctors Hospital Emergency Medicine Residency, where he served as Chief Resident. He has received multiple national awards, including recognition from the American Osteopathic Association, American College of Osteopathic Emergency Physicians, and Emergency Medicine Residents' Association.